DNMT1 and melanoma: Moreover, global DNA demethylation, induced by a DNMT inhibitor (DNMTi), reprogrammed MITFHI/PMELHI melanoma cells towards a de-differentiated profile associated with upregulation of predictive signatures of immunotherapy response.